COLLABORATION AGREEMENT FOR AN INVESTIGATOR-INITIATED CLINICAL TRIALLixte Biotechnology Holdings, Inc. • August 6th, 2019 • Pharmaceutical preparations • Madrid
On the one hand, Grupo Español de Investigación en Sarcomas (GEIS) with tax identification number G81890212, and address at C/ Diego de Leon 47, 28006 Madrid, Spain (hereinafter the “Sponsor”) represented in this act by Dr. Claudia Valverde Morales, in her capacity as President.
